TY - JOUR AU - Buxton, M. J. AU - Drummond, M. F. AU - Hout, B. A. AU - Prince, R. L. AU - Sheldon, T. A. AU - Szucs, T. PY - 1997 DA - 1997// TI - Modelling in economic evaluation: an unavoidable fact of life JO - Health Econ VL - 6 UR - https://doi.org/3.0.CO;2-W DO - 3.0.CO;2-W ID - Buxton1997 ER - TY - STD TI - Canadian Agency for Drugs and Technologies in Health (2006) Guidelines for the economic evaluation of health technologies, 3rd edn. Ottawa ID - ref2 ER - TY - JOUR AU - Caro, J. J. AU - Briggs, A. H. AU - Siebert, U. AU - Kuntz, K. M. PY - 2012 DA - 2012// TI - Modeling good research practices–overview: a report of the ISPOR-SMDM modeling good research practices task force-1 JO - Value Health VL - 15 UR - https://doi.org/10.1016/j.jval.2012.06.012 DO - 10.1016/j.jval.2012.06.012 ID - Caro2012 ER - TY - JOUR AU - Roberts, M. AU - Russell, L. B. AU - Paltiel, A. D. AU - Chambers, M. AU - McEwan, P. AU - Krahn, M. PY - 2012 DA - 2012// TI - Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2 JO - Value Health VL - 15 UR - https://doi.org/10.1016/j.jval.2012.06.016 DO - 10.1016/j.jval.2012.06.016 ID - Roberts2012 ER - TY - JOUR AU - Siebert, U. AU - Alagoz, O. AU - Bayoumi, A. M. AU - Jahn, B. AU - Owens, D. K. AU - Cohen, D. J. PY - 2012 DA - 2012// TI - State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3 JO - Value Health VL - 15 UR - https://doi.org/10.1016/j.jval.2012.06.014 DO - 10.1016/j.jval.2012.06.014 ID - Siebert2012 ER - TY - JOUR AU - Jit, M. AU - Brisson, M. PY - 2011 DA - 2011// TI - Modelling the epidemiology of infectious diseases for decision analysis: a primer JO - Pharmacoeconomics VL - 29 UR - https://doi.org/10.2165/11539960-000000000-00000 DO - 10.2165/11539960-000000000-00000 ID - Jit2011 ER - TY - JOUR AU - Heeg, B. M. AU - Damen, J. AU - Buskens, E. AU - Caleo, S. AU - de, C. F. AU - Van Hout, B. A. PY - 2008 DA - 2008// TI - Modelling approaches: the case of schizophrenia JO - Pharmacoeconomics VL - 26 UR - https://doi.org/10.2165/00019053-200826080-00002 DO - 10.2165/00019053-200826080-00002 ID - Heeg2008 ER - TY - JOUR AU - Kim, S. Y. AU - Goldie, S. J. PY - 2008 DA - 2008// TI - Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches JO - Pharmacoeconomics VL - 26 UR - https://doi.org/10.2165/00019053-200826030-00004 DO - 10.2165/00019053-200826030-00004 ID - Kim2008 ER - TY - JOUR AU - Barton, P. AU - Bryan, S. AU - Robinson, S. PY - 2004 DA - 2004// TI - Modelling in the economic evaluation of health care: selecting the appropriate approach JO - J Health Serv Res Policy VL - 9 UR - https://doi.org/10.1258/135581904322987535 DO - 10.1258/135581904322987535 ID - Barton2004 ER - TY - JOUR AU - Brennan, A. AU - Chick, S. E. AU - Davies, R. PY - 2006 DA - 2006// TI - A taxonomy of model structures for economic evaluation of health technologies JO - Health Econ VL - 15 UR - https://doi.org/10.1002/hec.1148 DO - 10.1002/hec.1148 ID - Brennan2006 ER - TY - STD TI - Chick SE (2007) Taxonomy of model structure for health economics. http://www2.wmin.ac.uk/hscmg/qmmhealth2007/talks/Chick_S.-.IMAHealth2007.-.Keynote.pdf. Accessed 20 Jan 2014 UR - http://www2.wmin.ac.uk/hscmg/qmmhealth2007/talks/Chick_S.-.IMAHealth2007.-.Keynote.pdf ID - ref11 ER - TY - JOUR AU - Cooper, K. AU - Brailsford, S. C. AU - Davies, R. PY - 2007 DA - 2007// TI - Choice of modelling technique for evaluating health care interventions JO - J Oper Res Soc VL - 58 ID - Cooper2007 ER - TY - JOUR AU - Stahl, J. E. PY - 2008 DA - 2008// TI - Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide JO - Pharmacoeconomics VL - 26 UR - https://doi.org/10.2165/00019053-200826020-00004 DO - 10.2165/00019053-200826020-00004 ID - Stahl2008 ER - TY - JOUR AU - Groot, K. B. AU - Weinstein, M. C. AU - Stijnen, T. AU - Heijenbrok-Kal, M. H. AU - Hunink, M. G. PY - 2010 DA - 2010// TI - Uncertainty and patient heterogeneity in medical decision models JO - Med Decis Mak VL - 30 UR - https://doi.org/10.1177/0272989X09342277 DO - 10.1177/0272989X09342277 ID - Groot2010 ER - TY - JOUR AU - Eddy, D. M. AU - Hollingworth, W. AU - Caro, J. J. AU - Tsevat, J. AU - McDonald, K. M. AU - Wong, J. B. PY - 2012 DA - 2012// TI - Model transparency and validation: a report of the ISPOR-SMDM modelling good practices task force JO - Med Decis Mak VL - 32 UR - https://doi.org/10.1177/0272989X12454579 DO - 10.1177/0272989X12454579 ID - Eddy2012 ER - TY - JOUR AU - Sculpher, M. AU - Fenwick, E. AU - Claxton, K. PY - 2000 DA - 2000// TI - Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application JO - Pharmacoeconomics VL - 17 UR - https://doi.org/10.2165/00019053-200017050-00005 DO - 10.2165/00019053-200017050-00005 ID - Sculpher2000 ER - TY - JOUR AU - Karnon, J. AU - Brown, J. PY - 1998 DA - 1998// TI - Selecting a decision model for economic evaluation: a case study and review JO - Health Care Manag Sci VL - 1 UR - https://doi.org/10.1023/A:1019090401655 DO - 10.1023/A:1019090401655 ID - Karnon1998 ER - TY - JOUR AU - Halpern, M. T. AU - Luce, B. R. AU - Brown, R. E. AU - Geneste, B. PY - 1998 DA - 1998// TI - Health and economic outcomes modeling practices: a suggested framework JO - Value Health VL - 1 UR - https://doi.org/10.1046/j.1524-4733.1998.120131.x DO - 10.1046/j.1524-4733.1998.120131.x ID - Halpern1998 ER - TY - JOUR AU - Palmer, A. J. AU - Clarke, P. AU - Gray, A. AU - Leal, J. AU - Lloyd, A. AU - Grant, D. PY - 2013 DA - 2013// TI - Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting JO - Value Health VL - 16 UR - https://doi.org/10.1016/j.jval.2013.01.002 DO - 10.1016/j.jval.2013.01.002 ID - Palmer2013 ER - TY - JOUR AU - Tsoi, B. AU - Jegathisawaran, J. AU - Tarride, J. -. E. AU - Blackhouse, G. AU - O’Reilly, D. PY - 2015 DA - 2015// TI - Do different decision-analytic modelling approaches produce different cost-effectiveness results? Insights from a systematic review of existing cross-validation studies JO - Expert Rev Pharmacoecon Outcomes Res VL - 15 UR - https://doi.org/10.1586/14737167.2015.1021336 DO - 10.1586/14737167.2015.1021336 ID - Tsoi2015 ER -